Navegar

Colección

Datos Estadísticas

Lista de

Tumor Suppressor Protein p53
20
"Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase" (2017) Giono, L.E.;Resnick-Silverman, L.;Carvajal, L.A. (...)Manfredi, J.J. Oncogene. 36(49):6762-6773
"Mechanisms involved in p53 downregulation by leptin in trophoblastic cells" (2015) Toro, A.R.;Pérez-Pérez, A.;Corrales Gutiérrez, I. (...)Varone, C.L. Placenta. 36(11):1266-1275
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation" (2014) Toro, A.R.;Maymó, J.L.;Ibarbalz, F.M. (...)Varone, C.L. PLoS ONE. 9(6)
"Folding of a cyclin box: Linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor ab pocket domain" (2013) Chemes, L.B.; Noval, M.G.; Sánchez, I.E.; De Prat-Gay, G. Journal of Biological Chemistry. 288(26):18923-18938
"BRCA1 and p53 regulate critical prostate cancer pathways" (2013) De Luca, P.;Moiola, C.P.;Zalazar, F. (...)De Siervi, A. Prostate Cancer and Prostatic Diseases. 16(3):233-238
"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17
"A monoclonal antibody against p53 cross-reacts with processing bodies" (2012) Thomas, M.G.;Luchelli, L.;Pascual, M. (...)Boccaccio, G.L. PLoS ONE. 7(5)
"MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs" (2012) Peche, L.Y.;Scolz, M.;Ladelfa, M.F. (...)Schneider, C. Cell Death and Differentiation. 19(6):926-936
"DNA damage-induced heterogeneous nuclear ribonucleoprotein K SUMOylation regulates p53 transcriptional activation" (2012) Pelisch, F.;Pozzi, B.;Risso, G. (...)Srebrow, A. Journal of Biological Chemistry. 287(36):30789-30799
"Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production" (2011) Ladelfa, M.F.; Toledo, M.F.; Laiseca, J.E.; Monte, M. Antioxidants and Redox Signaling. 15(6):1749-1761
"The serine/arginine-rich protein SF2/ASF regulates protein sumoylation" (2010) Pelisch, F.;Gerez, J.;Druker, J. (...)Srebrow, A. Proceedings of the National Academy of Sciences of the United States of America. 107(37):16119-16124
"Transcriptional upregulation of p19INK4d upon diverse genotoxic stress is critical for optimal DNA damage response" (2009) Ceruti, J.M.;Scassa, M.E.;Marazita, M.C. (...)Cánepa, E.T. International Journal of Biochemistry and Cell Biology. 41(6):1344-1353
"Telomerase activity in fine needle aspiration biopsy samples: Application to diagnosis of human thyroid carcinoma" (2006) Guerra, L.N.;Miler, E.A.;Moiguer, S. (...)Burdman, J.A. Clinica Chimica Acta. 370(1-2):180-184
"Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus" (2004) Galigniana, M.D.;Harrell, J.M.;O'Hagen, H.M. (...)Pratt, W.B. Journal of Biological Chemistry. 279(21):22483-22489
"Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex" (2004) Galigniana, M.D.; Morishima, Y.; Gallay, P.A.; Pratt, W.B. Journal of Biological Chemistry. 279(53):55754-55759
"Delta-aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines." (2002) De Siervi, A.;Vazquez, E.S.;Rezaval, C. (...)del Batlle, A.M. BMC cancer [electronic resource]. 2(1):6